张笑天,张莉莉,孙苏安.miR-34a靶向调控SOX7表达抑制垂体腺瘤细胞增殖.[J].中南医学科学杂志.,2020,(6):588-591, 603.
miR-34a靶向调控SOX7表达抑制垂体腺瘤细胞增殖
Inhibitory effect of miR-34a on the proliferation of pituitary adenoma cell by targeting SOX7
投稿时间:2019-08-15  修订日期:2020-06-01
DOI:10.15972/j.cnki.43-1509/r.2020.06.008
中文关键词:  miR-34a  SOX7  垂体腺瘤细胞  增殖
英文关键词:miR-34a  SOX7  pituitary adenoma cell  proliferation
基金项目:
作者单位
张笑天 南京医科大学附属淮安第一医院病理科,江苏 淮安 223300 
张莉莉 南京医科大学附属淮安第一医院病理科,江苏 淮安 223300 
孙苏安 南京医科大学附属淮安第一医院病理科,江苏 淮安 223300 
摘要点击次数: 547
全文下载次数: 441
中文摘要:
      探讨miR-34a通过靶向调控SOX7表达对垂体腺瘤细胞增殖的影响。结果显示,miR-34a mimics转染组和siRNA-SOX7组细胞活力、S期、G2期分别低于NC-miR-34a转染组和NC-SOX7转染组,细胞凋亡率和G1期分别高于NC-miR-34a转染组和NC-SOX7转染组。miR-34a mimics转染组SOX7 mRNA、SOX7蛋白的相对表达量低于NC-miR-34a转染组。结果表明,miR-34a可以通过靶向抑制SOX7表达抑制垂体腺瘤细胞增殖。
英文摘要:
      To investigate the effects of miR-34a on the proliferation of pituitary adenoma cell through the targeted regulation of SOX7 expression. The results showed that the cell vitality, S and G2 phases of the miR-34a mimics transfection group and siRNA-SOX7 transfection group were lower than those of the NC-miR-34a transfection group and the NC-SOX7 transfection group, respectively, and the apoptosis rate and G1 phase were higher than those of the NC-miR-34a transfection group and the NC-SOX7 transfection group, respectively. The relative expression levels of SOX7 mRNA and SOX7 protein in miR-34a mimics transfection group were lower than those in NC-miR-34a transfection group. The results indicated that miR-34a can inhibit the proliferation of pituitary adenoma cell by inhibiting SOX7 expression.
查看全文  查看/发表评论  下载PDF阅读器
关闭
function PdfOpen(url){ var win="toolbar=no,location=no,directories=no,status=yes,menubar=yes,scrollbars=yes,resizable=yes"; window.open(url,"",win); } function openWin(url,w,h){ var win="toolbar=no,location=no,directories=no,status=no,menubar=no,scrollbars=yes,resizable=no,width=" + w + ",height=" + h; controlWindow=window.open(url,"",win); } &et=467AED4E95852F8455B53FBC4143368D468228968C4BC39AE12EB416E16EFA1E797BD2CC500E634ED21C393E5969DAFB4FAE1287627DFE34C2301AB6B5B80A3375D9BB42075C6A1F80EB95C3F90B17D9C8EE6AE56D9F4DADFD709EA4F8B1D3D4&pcid=A9DB1C13C87CE289EA38239A9433C9DC&cid=BB33F1C95224820A&jid=6A20DF2A798996E24F064D5ECF83A153&yid=0D1D160AB8016934&aid=E91612AB43BC37D4455EBB615698456B&vid=&iid=B31275AF3241DB2D&sid=4964C30D71DF45FF&eid=426753F9A968C33A20C7C84DBC5EAF77&fileno=20200608&flag=1&is_more=0">